STOLL BERNE, an Oregon class action and securities fraud law firm, is investigating potential claims concerning whether Galena Biopharma, Inc. (“Galena”) (NASDAQ: GALE), its board of directors or officers violated state or federal securities laws, or breached fiduciary duties owed to shareholders.
The investigation relates to the recent drop in Galena’s stock price following reports questioning Galena’s practices with respect to stock promotion.
If you purchased Galena shares and wish to discuss the matter with one of our lawyers, please contact Keith Dubanevich or Jennifer Wagner.